Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
about
Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care HospitalRecurrent vulvovaginal candidiasis.Microfungi in drinking water: the role of the frog Litoria caeruleaGuideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists aGenital mycotic infections in patients with diabetes.BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trialIn vitro anti-Candida activity of lidocaine and nitroglycerin: alone and combined.Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection.Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013)Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay.Biofilm formation in clinical Candida isolates and its association with virulenceAzole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Non-response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism.Association of Diabetes and Insulin Therapy With Risk of Hospitalization for Infection and 28-Day Mortality Risk.Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).In vitro activity of 23 tea extractions and epigallocatechin gallate against Candida species.Vaginal thrush: quality of life and treatments.Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.Boric Acid and Commercial Organoboron Products as Inhibitors of Drug-Resistant Candida albicans.A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.Candida vaginitis in non-pregnant patients: a study of antifungal susceptibility testing and virulence factors.Species Diversity, Antifungal Susceptibility, and Virulence Attributes of Candida Colonising the Oral Cavities of Adult Diabetic Patients
P2860
Q33666272-524A877F-7258-4F1C-BDE5-924635388AFDQ33798920-12668E50-DE9B-4DF1-92CA-C99B7879D55EQ34196918-6F6D9C80-66E4-421B-88C9-7774DE55A887Q34269717-20CD2749-9EE4-4A57-99F1-69961F1ECA81Q34349532-00A283BF-FE55-4896-9D8C-D17D2B7E119DQ35888829-FA13C61D-B3DF-4874-B392-70D287FA751FQ35997689-66977C1E-19A4-41B5-B86A-EAAD6923A616Q36539905-26449E13-DC86-4D11-BA4C-DE84740A7E58Q36743194-5050540B-A4E5-432F-8F52-FA57DDFFE030Q36870890-99A9A0F0-09A1-4B33-9314-80F8D5C62A83Q37274233-C0C2EF25-8D20-47AA-B35E-CEB49D141E22Q37580801-D6724131-E2A9-4123-B927-A15434AE497BQ38696236-88A02AF3-7C20-44A7-A773-E3B16F575CFEQ38827140-BCA981CB-AC17-4BF2-96EC-FAE38C647EE8Q38973158-6E13EC7E-000F-4B5C-B705-DFD8594CE3E2Q39035805-EAF78F58-4918-4847-B49C-0AC353CB0DCBQ41531264-13A06335-3857-4DEF-B83D-3CF880DC38A7Q42876396-8E05D08C-82BA-406D-B493-3CB3A5ADFDC3Q46211946-D288D843-EB33-4252-8991-2EC7851AFA25Q48218743-6CA5A2F9-7942-4440-B169-B88BF18B63CEQ50566261-FF6CBF30-DF6A-4648-B1A3-8EC25D3E8905Q51245144-7AD68F76-3050-432D-9552-D2698577DBBBQ59058024-E4556ED5-A87E-4152-871E-E9DD9DDC18DA
P2860
Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Prevalence of Candida glabrata ...... and vulvovaginal candidiasis.
@en
Prevalence of Candida glabrata ...... and vulvovaginal candidiasis.
@nl
type
label
Prevalence of Candida glabrata ...... and vulvovaginal candidiasis.
@en
Prevalence of Candida glabrata ...... and vulvovaginal candidiasis.
@nl
prefLabel
Prevalence of Candida glabrata ...... and vulvovaginal candidiasis.
@en
Prevalence of Candida glabrata ...... and vulvovaginal candidiasis.
@nl
P2093
P356
P1433
P1476
Prevalence of Candida glabrata ...... and vulvovaginal candidiasis.
@en
P2093
Debarti Ray
Deepti Goswami
Narayana Kochupillai
Piyali Mandal
Ravinder Goswami
Uma Banerjee
Vatsla Dadhwal
Vishnubhatla Sreenivas
P304
P356
10.2337/DC06-1469
P407
P577
2007-02-01T00:00:00Z